ZEN Graphene Ebitda Over Time

ZTEK Stock  USD 0.90  0.02  2.17%   
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out ZEN Graphene Performance and ZEN Graphene Correlation.
  
EBITDA is expected to rise to about (9.5 M) this year.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ZEN Graphene. If investors know ZEN will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ZEN Graphene listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.08)
Revenue Per Share
0.001
Quarterly Revenue Growth
2.037
Return On Assets
(0.28)
Return On Equity
(0.55)
The market value of ZEN Graphene Solutions is measured differently than its book value, which is the value of ZEN that is recorded on the company's balance sheet. Investors also form their own opinion of ZEN Graphene's value that differs from its market value or its book value, called intrinsic value, which is ZEN Graphene's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ZEN Graphene's market value can be influenced by many factors that don't directly affect ZEN Graphene's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ZEN Graphene's value and its price as these two are different measures arrived at by different means. Investors typically determine if ZEN Graphene is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ZEN Graphene's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Specify up to 10 symbols:

Cross Equities Ebitda Analysis

Compare ZEN Graphene Solutions and related stocks such as Milestone Scientific, Pro Dex, and Top Glove Ebitda Over Time
Select Fundamental
Price To Sales RatioDividend Yield
Ptb RatioDays Sales Outstanding
Book Value Per ShareFree Cash Flow Yield
Invested CapitalOperating Cash Flow Per Share
Average PayablesStock Based Compensation To Revenue
Capex To DepreciationPb Ratio
Ev To SalesFree Cash Flow Per Share
RoicInventory Turnover
Net Income Per ShareDays Of Inventory On Hand
Payables TurnoverSales General And Administrative To Revenue
Average InventoryResearch And Ddevelopement To Revenue
Capex To RevenueCash Per Share
PocfratioInterest Coverage
Payout RatioCapex To Operating Cash Flow
Pfcf RatioDays Payables Outstanding
Net Current Asset ValueIncome Quality
RoeTangible Asset Value
Ev To Operating Cash FlowPe Ratio
Return On Tangible AssetsEv To Free Cash Flow
Earnings YieldIntangibles To Total Assets
Net Debt To E B I T D ACurrent Ratio
Tangible Book Value Per ShareReceivables Turnover
Shareholders Equity Per ShareDebt To Equity
Capex Per ShareGraham Net Net
Average ReceivablesRevenue Per Share
Interest Debt Per ShareDebt To Assets
Enterprise Value Over E B I T D AShort Term Coverage Ratios
Price Earnings RatioOperating Cycle
Price Book Value RatioPrice Earnings To Growth Ratio
Days Of Payables OutstandingDividend Payout Ratio
Price To Operating Cash Flows RatioPrice To Free Cash Flows Ratio
Pretax Profit MarginEbt Per Ebit
Operating Profit MarginEffective Tax Rate
Company Equity MultiplierLong Term Debt To Capitalization
Total Debt To CapitalizationReturn On Capital Employed
Debt Equity RatioEbit Per Revenue
Quick RatioDividend Paid And Capex Coverage Ratio
Net Income Per E B TCash Ratio
Cash Conversion CycleOperating Cash Flow Sales Ratio
Days Of Inventory OutstandingDays Of Sales Outstanding
Free Cash Flow Operating Cash Flow RatioCash Flow Coverage Ratios
Price To Book RatioFixed Asset Turnover
Capital Expenditure Coverage RatioPrice Cash Flow Ratio
Enterprise Value MultipleDebt Ratio
Cash Flow To Debt RatioPrice Sales Ratio
Return On AssetsAsset Turnover
Net Profit MarginGross Profit Margin
Price Fair ValueReturn On Equity
2010201120122013201420152016201720182019202020212022202320242025
MLSS(2.1 M)(991.5 K)(596.2 K)268.2 K(1.6 M)(3 M)(6.4 M)(4.7 M)(4 M)(106.9 K)(7.4 M)(7.3 M)(8.7 M)(7 M)(6.3 M)(5.9 M)
PDEX(400 K)(718 K)(1.3 M)(275 K)(318 K)1.4 M3.4 M4.2 M5.7 M8.7 M8.1 MM6.6 M8.3 M9.6 M10.1 M
POCI300 K(1.3 M)(1.2 M)(1.2 M)(1.3 M)(1.1 M)(970.3 K)(321.4 K)(445.9 K)(1.3 M)50.2 K(526.6 K)(427.8 K)(2.5 M)(2.3 M)(2.1 M)
NEPH(437.9 K)(2.2 M)(3.2 M)(3.4 M)(2.5 M)(3.2 M)(2.6 M)(2 M)(2.9 M)(3.2 M)(3.9 M)(2.2 M)(3.9 M)(1.4 M)193 K202.7 K
KRMD(546.3 K)1.4 M1.3 M1.2 M1.4 M1.4 M(432.7 K)1.5 M3.3 M7.7 M1.6 M(6.6 M)(10.2 M)(9.4 M)(5.6 M)(5.3 M)
LMAT(282 K)7.2 M3.7 M7.3 M7.8 M10.8 M19.9 M25.2 M13.3 M21.2 M36.9 M46 M36.9 M49 M66.8 M70.1 M
HOLX1.8 M327.9 M397.5 M447.2 M965.3 M1.1 B949.7 MB597.5 M1.5 B2.9 B2.1 B1.1 B1.3 B1.5 B1.6 B
HAE157.3 M84.9 M60.7 M129.1 M126.6 M126.4 M128.9 M145.4 M193 M264.2 M142.2 M178.5 M249.3 M265.6 M305.4 M320.7 M
ICUI6.9 M48.8 M80.3 M71.5 M68.7 M113.2 M132.7 M68.4 M190.5 M148.4 M194.1 M223.5 M191.5 M253.2 M43 M74 M
NVST530 M530 M530 M530 M530 M530 M530 M508.1 M428.4 M279 M205.6 M460.5 M484.4 M31.5 M(883.8 M)(839.6 M)
COO57.9 M312.6 M372.7 M340.2 M285 M382.6 M495.8 M585.7 M672.2 M622.9 M863.7 M908.6 M885.9 M705.7 M811.6 M852.1 M
ANGO9.5 M44.7 M66.6 M56.6 M66.3 M56.1 M60.3 M49.4 M98.8 M9.6 M(8.9 M)11.1 M12.2 M(14.3 M)(16.4 M)(15.6 M)
INFU(24.5 K)10.3 M10.3 M14.2 M15.5 M17.1 M11.7 M9.6 M11.7 M15.8 M22.8 M17.2 M15.1 M16.5 M6.9 M11.2 M
MMSI(300 K)39.2 M30.7 M31.9 M40.9 M38.5 M34.7 M45.2 M60.5 M38.6 M102.7 M153.5 M181.2 M231.4 M295.9 M310.7 M
AKYA(10.8 M)(10.8 M)(10.8 M)(10.8 M)(10.8 M)(10.8 M)(10.8 M)(10.8 M)(10.8 M)(10.8 M)(10.1 M)(35.2 M)(58.8 M)(45.6 M)(46.7 M)(49.1 M)

ZEN Graphene Solutions and related stocks such as Milestone Scientific, Pro Dex, and Top Glove Ebitda description

My Equities

My Current Equities and Potential Positions

ZEN Graphene Solutions
ZTEK
Specialization
Health Care, Health Care Equipment & Services
LocationOntario; Canada
ExchangeNASDAQ Exchange
USD 0.9
When determining whether ZEN Graphene Solutions is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if ZEN Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Zen Graphene Solutions Stock. Highlighted below are key reports to facilitate an investment decision about Zen Graphene Solutions Stock:
Check out ZEN Graphene Performance and ZEN Graphene Correlation.
You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
ZEN Graphene technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of ZEN Graphene technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of ZEN Graphene trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...